| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Third National Report on the implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
109449
Status
Published
Date of creation
2015-11-28 20:43 UTC (andrew.bowers@cbd.int)
Date of publication
2015-11-28 20:43 UTC (andrew.bowers@cbd.int)

This document is also available in the following languages:
Origin of report
1. Country
  • Democratic Republic of the Congo
Contact officer for report
Coordinates
Benjamin TOIRAMBE BAMONINGA
Directeur-Chef de Service de Développement Durable
Ministère de l'Environnement, Conservation de la Nature et Développement Durable
12348 KIN 1
Democratic Republic of the Congo
Phone:+243 999954148
Email:toirambe2014@gmail.com
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
FR
Ministère du Commerce, Ministère de l'Agriculture (Service national des Semences), Direction Générale  des Douanes et Accises (DGDA), Office Congolais de Contrôle (OCC); Centre régional d'étude nucléaire (Laboratoire de biotechnologie), Cellule Juridique du Ministère en charge de l'Environnement et du Développement Durable, Direction de Développement Durable (DDD), et Institut National d'Etude et Recherche Agronomiques (INERA);
Submission
10. Date of submission
2015-11-21
11. Time period covered by this report
Start date
2011-08-16
11. Time period covered by this report
End date
2015-10-31
Party to the Cartagena Protocol on Biosafety
Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
14. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
This question is relevant to indicators 1.1.1, 2.1.1, 2.1.2, and 3.1.2 of the Strategic Plan
  • A domestic regulatory framework is partially in place
15. If you indicated that a national biosafety framework exists in the above question, when did it become operational?
This question is relevant to the indicator 1.1.1 of the Strategic Plan
  • 2008
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • No instruments are in place
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • Yes
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • Less than 5
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Yes
21. Here you may provide further details on the implementation of Article 2 in your country
FR
Les commentaires suivants concernent les dispositions légales et reglementaires qui peuvent s'appliquer pour la biosécurité ainsi que le nombre d'employés affectés à la gestion de la prévention des risques biotechnologiques.
En ses articles 53 et 202 point 36.m, la Constitution de la RD Congo du 16 février 2006 tout comme la Loi du 09 juillet portant principes fondamentaux relatifs à la protection de l'environnement, en ses articles 62 et 63 jettent d'ores et déjà les bases d'une législation sur la gestion des risques biotechnologiques ainsi que sur l'utilisation de la biotechnologie.
D'autres textes juridiques de portée générale réglementent indirectement les organismes vivants modifiés. Il s'agit notamment de:
- la législation sur l'exercice du commerce (loi n°73-009 du 05 janvier 1973 telle que modifiée et complétée à ce jour;
- la législation sur la forêt (Code forestier).
La Loi n°14/003 du 11 février 2014 relative à la conservation de la nature contient aussi des dispositions susceptibles d'être capitalisées dans le cadre de la biosécurité notamment les dispositions relatives à l'étude d'impact environnemental et social.
La Loi n°11/022 du 24 décembre 2011 portant principes fondamentaux relatifs à l'agriculture stipule à son article 71 que le Gouvernement veille à ce que la mise au point, l'utilisation, le transfert et la libération dans l'agriculture des organismes génétiquement modifiés et des pesticides se fassent de manière à éviter ou à réduire les risques pour l'environnement et la santé. Il veille également à ce que certaines pratiques agricoles n'aient pas d'impact négatif sur l'environnement et la santé.
En ce qui concerne le personnel affecté de façon permanente aux fonctions liées à la prévention des risques biotechnologiques, le nouveau cadre organique du Secrétariat Général à l'Environnement et Conservation de la Nature, approuvé provisoirement, crée au sein de la Direction de Développement Durable, Autorité Nationale Compétente au titre du Protocole de Cartagena, un nouveau Bureau Biosécurité qui a pour mission d'assurer le suivi de la mise en œuvre des décisions et recommandations prises dans le cadre des Réunions des Parties au Protocole de Cartagena, la gestion du Centre d'échange national ainsi que le suivi de la mise en œuvre du cadre national de biosécurité.
Trois personnes sont affectées à temps plein audit Bureau au lieu de quatre tel que prévu par le cadre organique.
Article 5 - Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • No
24. Here you may provide further details on the implementation of Article 5 in your country:
FR
Les organismes vivants modifiés qui sont des produits pharmaceutiques ne font pas l'objet d'une  réglementation spécifique. Cependant, les articles 62 et 63 de la loi portant principes fondamentaux relatifs à la protection de l'environnement, traitant de tous les organismes vivants modifiés sans distinction aucune, jettent déjà les bases pour une législation spécifique des OVM.
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
This question is relevant to indicator 1.8.1 of the Strategic Plan
  • No
26. Does your country regulate the contained use of LMOs?
This question is relevant to indicators 1.1.2 and 1.8.2 of the Strategic Plan
  • No
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol OR a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
This question is relevant to indicators 1.1.2 and 3.1.4 of the Strategic Plan
  • No
30. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
32. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • No
33. Has your country established legal requirements for the accuracy of information contained in the notification?
  • No
34. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
This question is relevant to indicator 1.1.4 of the Strategic Plan
  • No
35. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
This question is relevant to indicator 1.1.5 of the Strategic Plan
  • No
38. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
39. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
46. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment
FR
En l'absence d'une Loi spécifique sur la biosécurité et des mesures d'application y afférentes,  il sied d'affirmer que les articles 7 à 10 du Protocole de Cartagena ne sont appliqués à proprement parlé.
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
47. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
This question is relevant to indicator 1.1.2 of the Strategic Plan
  • No
48. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • No
49. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
This question is relevant to indicator 3.1.5 of the Strategic Plan
  • No
50. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
This question is relevant to indicator 1.1.2 of the Strategic Plan
  • No
51. Has your country indicated its needs for financial and technical assistance and capacity-building in respect of LMOs-FFP?
This question is relevant to indicator 1.2.1 of the Strategic Plan
  • No
52. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
58. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP
FR
En l'absence d'une Loi spécifique sur la biosécurité et des mesures d'application y afférentes,  il sied d'affirmer que l'article 11 du Protocole de Cartagena n'est pas appliqué à proprement parlé.
Article 12 – Review of decision
59. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • No
60. Has your country ever received a request for a review of a decision?
  • No
61. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
62. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
66. Here you may provide further details on the implementation of Article 12 in your country
FR
En l'absence d'une Loi spécifique sur la biosécurité et des mesures d'application y afférentes,  il sied d'affirmer que l'article 12 du Protocole de Cartagena n'est pas appliqué à proprement parlé.
Article 13 – Simplified procedure
67. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
68. Has your country ever applied the simplified procedure?
  • No
70. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
71. Here you may provide further details on the implementation of Article 13 in your country
FR
En l'absence d'une Loi spécifique sur la biosécurité et des mesures d'application y afférentes,  il sied d'affirmer que l'article 13 du Protocole de Cartagena n'est pas appliqué à proprement parlé .
Article 14 – Bilateral, regional and multilateral agreements and arrangements
72. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • Yes
73. If you answered Yes to question 72, how many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
This question is relevant to indicator 1.2.8 of the Strategic Plan
  • One or more
74. If you answered Yes to question 72, has your country informed the Parties through the BCH of the agreements or arrangements?
This question is relevant to indicator 3.1.5 of the Strategic Plan
  • No
76. Here you may provide further details on the implementation of Article 14 in your country
FR
Dans le cadre du Marché Commun pour l'Afrique de l'Est et Australe (COMESA) auquel la RD Congo est Partie, les politiques et  les directives pour manipuler les cultures commerciales génétiquement modifiées, le commerce des OVM et l'aide alimentaire d'urgence contenant les OVM ont été développées et adoptées.
En ce qui concerne de manière spécifique les cultures commerciales génétiquement modifiées, ces politiques et lignes directrices ont pour objectifs de fournir aux Etats membres du COMESA un mécanisme d'évaluation régionale centralisée des OGM destinés à une culture commerciale et promouvoir les exigences harmonisées d'évaluation des risques selon des lignes directrices développées au niveau international pour les OVM.
Le champs d'application de ces politiques et directives sont l'évaluation centralisée risques à travers l'opérationnalisation des sous-comités régionaux d'évaluation des risques liés aux OVM dans les pays COMESA, l'évaluation des risques pour la santé humaine ou l'environnement ainsi que les considérations socio-économiques, culturelles ou autres réalisées en accord avec les cadres nationaux de biosécurité.

Les politiques et les directives COMESA reconnaissent dûment la souveraineté et l'existence de lois et des politiques nationales de biosécurité. Un comité d'experts (PoE) a été établi en tant que comité permanent de guidage des politiques au sein du COMESA pour les domaines liés aux biotechnologies et à la biosécurité.
Les politiques et les directives COMESA concernent :

- la plantation des cultures génétiquement modifiées à des fins commerciales;
- le commerce des produits génétiquement modifiés; et
- l'aide alimentaire d'urgence contenant les cultures génétiquement modifiées.

En vue d'informer le processus de décision basée sur l'évidence scientifique entre les états membres, les politiques et les lignes directrices COMESA adoptent une approche en fonction de 4 categories:
- le commerce des semences génétiquement modifiées;
- le commerce des produits génétiquement modifiés destinés à l'alimentation humaine, animale ou à la transformation;
- les produits génétiquement modifiés destinés à l'alimentation humaine, animale ou à la tranformation en transit; et
- les produits destinés à l'alimentation humaine, animale ou à la transformation avec une faible présence des organismes génétiquement modifiés
Articles 15 & 16 – Risk Assessment and Risk Management
77. Has your country established a national framework for conducting risk assessments prior to taking decisions regarding LMOs?
  • No
79. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
This question is relevant to indicator 2.2.3 of the Strategic Plan
a) Risk assessment:
  • One or more
b) Management / Control:
  • None
c) Monitoring:
  • None
80. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • No
81. Is your country using the "Manual on Risk Assessment of LMOs" (developed by CBD Secretariat) for training in risk assessment?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • No
82. Is your country using the "Guidance on Risk Assessment of LMOs" (developed by the Online Forum and the AHTEG on Risk Assessment and Risk Management) for training in risk assessment?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • No
83. Are the currently available training materials or technical guidance on risk assessment and/or risk management of LMOs sufficient?
This question is relevant to indicator 2.2.6 of the Strategic Plan
  • Not applicable
84. Does your country have the capacity to detect, identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
This question is relevant to indicators 1.4.2 and 1.6.3 of the Strategic Plan
a) Detect:
  • Yes
b) Identify:
  • Yes
c) Assess:
  • No
d) Monitor:
  • No
85. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment or risk management, or for evaluating risk assessment reports submitted by notifiers?
This question is relevant to indicators 1.3.1 of the Strategic Plan
a) Risk assessment:
  • No
b) Risk management:
  • No
86. Is your country using the "Guidance on Risk Assessment of LMOs" (developed by the Online Forum and the AHTEG on Risk Assessment and Risk Management) for conducting risk assessment or risk management, or for evaluating risk assessment reports submitted by notifiers?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • No
87. Has your country adopted any common approaches to risk assessment with other countries?
This question is relevant to indicator 1.3.2 of the Strategic Plan
  • Yes
88. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
This question is relevant to indicator 1.4.1 of the Strategic Plan
  • No
89. Has your country ever conducted a risk assessment of an LMO including any type of risk assessment of LMOs, e.g. for contained use, field trials, commercial purposes, direct use as food, feed, or for processing?
This question is relevant to indicator 1.3.3 of the Strategic Plan
  • No
94. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • No
95. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • No
96. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
This question is relevant to indicator 2.2.4 of the Strategic Plan
  • Yes
97. Here you may provide further details on the implementation of Articles 15 and 16 in your country
FR
Dans le système national de recherche agricole, il existe des structures qui abordent les questions liées aux OGM, en particulier les plantes génétiquement modifiées dans leurs programmes. Les premières expériences d'un recours aux biotechnologies en RD Congo sont actuellement conduits  par des organismes publics ou privés ci-après :
- l'Institut National pour l'Etude et la Recherche agronomique (INERA) conduit des activités de recherche dans le domaine de biotechnologie classique  ;
- le Centre National de Recherche en Sciences Naturelles (CRSN-Lwiro) . On retrouve dans son département de Biologie quelques travaux préliminaires ayant trait à la biologie moléculaire et à la biotechnologie en général;
- le Laboratoire de Biotechnologie et Biologie moléculaire  du Commissariat Général à l'Energie Atomique / Centre Régional d'Etudes Nucléaires de Kinshasa (CGEA / CREN-K.) est doté d'une équipe qualifiée de chercheurs et d'un équipement approprié sur la culture des tissus in vitro et les analyses moléculaires dans le cadre de la coopération avec l'Agence Internationale de l'Energie Atomique (AIEA).
Le budget extrêmement limité alloué à ces structure ne permet cependant pas au pays de s'équiper de matériel nécessaire pour la recherche et le contrôle en matière de plantes transgéniques.
Dans le cadre de la Biotechnologie moderne, certains travaux ont été déjà réalisés dans le pays sur les Bacillus sp. , les Agrobacteriumsp, de Rhizobium et les lectines (Tous ayant le gène d'intérêt agronomique). Leur orientation vers la génomique en Agriculture serait une avancée significative
Il y a déjà de la compétence pour la détection des OGM, dans certaines instances d'évaluation scientifique ou de contrôle notamment l'Institut National de Recherche Biomédical (INRB), le Laboratoire vétérinaire de Kinshasa, labo-CREN-K, le laboratoire national des semences (SENASEM), l'Office Congolais de Contrôle (OCC), etc.
Les équipements de base pour la detection des OGMs sont disponibles dans certains de ces  laboratoires. Cependant, il ya un besoin criant en consommables des laboratoires.
Il convient de préciser qu'en ce qui concerne le cadre commun d'évaluation des risques, il s'agit de celui adopté par les pays COMESA à travers les politiques et directives sur la biosecurité.
Article 17 – Unintentional transboundary movements and emergency measures
98. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • No
99. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • No
100. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
This question is relevant to indicator 1.8.3 of the Strategic Plan
  • No
101. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
Article 18 – Handling, transport, packaging and identification
106. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • No
107. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
This question is relevant to indicator 1.6.1 of the Strategic Plan
  • No
108. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
This question is relevant to indicator 1.6.1 of the Strategic Plan
  • No
110. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
This question is relevant to indicator 1.6.2 of the Strategic Plan
  • No
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
This question is relevant to indicator 1.6.2 of the Strategic Plan
  • No
114. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
This question is relevant to indicator 1.6.4 of the Strategic Plan
  • No
116. How many customs officers in your country have received training in the identification of LMOs?
This question is relevant to indicator 2.3.1 of the Strategic Plan
  • None
117. Has your country established procedures for the sampling and detection of LMOs?
  • No
118. How many laboratory personnel in your country have received training in detection of LMOs?
This question is relevant to indicator 2.3.1 of the Strategic Plan
  • One or more
119. Does your country have reliable access to laboratory facilities for the detection of LMOs?
This question is relevant to indicator 2.3.2 of the Strategic Plan
  • Yes
120. How many laboratories in your country are certified for LMO detection?
This question is relevant to indicator 2.3.3 of the Strategic Plan
  • None
Article 19 – Competent National Authorities and National Focal Points
124. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes
125. Here you may provide further details on the implementation of Article 19 in your country
FR
La Direction de Développement Durable du Ministère en charge de l'environnement et du développement durable a été désignée comme l'unique Autorité nationale compétente au titre du Protocole de Cartagena. Elle dispose de toutes les capacités   requises pour assurer les fonctions administratives y afferentes.
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
126. Please provide an overview of the status of the mandatory information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
This question is relevant to indicator 3.1.5 of the Strategic Plan
a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information not available
b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information not available
c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information available but not in the BCH
d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available and in the BCH
f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information not available
j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
127. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • No
128. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes
129. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • Yes, in some cases
130. Has your country experienced difficulties accessing or using the BCH?
This question is relevant to indicator 4.1.8 of the Strategic Plan
  • No
131. Is the information submitted by your country to the BCH complete and up-to date?
  • No
132. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years:
This question is relevant to indicator 4.3.1 of the Strategic Plan
  • 5 or more
133. Please indicate the number of biosafety related publications that has been made available in your country in the last year:
This question is relevant to indicator 4.3.2 of the Strategic Plan
  • None
135. Here you may provide further details on the implementation of Article 20 in your country
FR
Les détails ci-après concernent la question 128: La coordination entre le correspondant national du Protocole de Cartagena, celui du Centre d'échange et l'Autorité nationale compétente fonctionne bien étant donné que l'ensemble de ces fonctions sont assurées au sein d'une même structure, la Direction de Développement Durable du Ministère en charge de l'Environnement et Développement Durable.
Article 21 – Confidential information
136. Has your country established procedures to protect confidential information received under the Protocol?
  • No
137. Does your country allow the notifier to identify information that is to be treated as confidential?
  • No
Article 22 – Capacity-building
139. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
This question is relevant to indicator 1.2.6 and 3.1.8 of the Strategic Plan
  • No
140. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
141. If you answered Yes to question 140, how were these resources made available?
  • Regional channels
142. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • No
144. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
145. If you answered Yes to question 144, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 157.
  • Easy
146. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Development of national biosafety frameworks
  • Building Capacity for Effective Participation in the BCH (Phase I)
  • Building Capacity for Effective Participation in the BCH (Phase II)
147. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
148. If you answered Yes to question 147, in which of the following areas were these activities undertaken?
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Identification of LMOs, including their detection
149. During the current reporting period, has your country carried out a capacity-building needs assessment?
This question is relevant to indicator 1.2.1 of the Strategic Plan
  • Yes
150. If you answered Yes to question 149, has this information been submitted to the BCH?
This question is relevant to indicator 1.2.1 of the Strategic Plan
  • No
151. Does your country still have capacity-building needs?
This question is relevant to indicator 1.2.7 of the Strategic Plan
  • Yes
152. If you answered Yes to question 151, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
153. Has your country developed a capacity-building strategy or action plan?
This question is relevant to indicator 1.2.2 of the Strategic Plan
  • No
154. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
This question is relevant to indicator 1.2.4 of the Strategic Plan
  • No
155. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
This question is relevant to indicator 1.2.3 of the Strategic Plan
  • Less than 1 per year
156. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • No
157. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds
FR
En ce qui concerne l'obtention des fonds du Fonds pour l'Environnement Mondial, dans le cadre du FEM-5, la République Démocratique du Congo participe avec 5 autres pays de l'Afrique Australe au projet sous régional "Multicountry project to strengthen institutional capacity on LMO testing in support of national decision making". Le document du projet est en cours d'élaboration.
Dans le cadre du FEM-6, la RD Congo propose de soumettre un projet sur la mise en œuvre de son Cadre national de biosécurité.
Pour ces deux projets, l'agence d'éxécution est le Programme des Nations Unies pour l'Environnement (PNUE).
Article 23 – Public awareness and participation
158. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • No
159. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
This question is relevant to indicator 5.3.2 of the Strategic Plan
  • No
160. Does your country have any awareness and outreach programmes on biosafety?
This question is relevant to indicator 5.3.1 of the Strategic Plan
  • No
162. Has your country established a biosafety website searchable archives, national resource centres or sections in existing national libraries dedicated to biosafety educational materials?
This question is relevant to indicators 2.5.3 and 5.3.3 of the Strategic Plan
  • No
163. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
This question is relevant to indicator 5.2.1 of the Strategic Plan
  • None
164. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • No
165. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
This question is relevant to indicator 2.5.1 of the Strategic Plan
  • Yes
166. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
This question is relevant to indicator 2.5.1 of the Strategic Plan
  • Yes
167. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
This question is relevant to indicator 2.5.2 of the Strategic Plan
  • No
170. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • No
171. How many academic institutions in your country are offering biosafety education and training courses and programmes?
This question is relevant to indicator 2.7.1 of the Strategic Plan
  • None
172. Please indicate the number of educational materials and/or online modules on biosafety that are available and accessible to the public in your country:
This question is relevant to indicators 2.7.2 and 5.3.4 of the Strategic Plan
  • None
173. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • No
175. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • Never
Article 24 – Non-Parties
177. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
178. Has your country ever imported LMOs from a non-Party?
  • No
179. Has your country ever exported LMOs to a non-Party?
  • No
Article 25 – Illegal transboundary movements
184. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • No
185. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • No
186. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
If you replied Never to question 186 please go to question 191
  • Never
Article 26 – Socio-economic considerations
192. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
This question is relevant to indicator 1.7.2 of the Strategic Plan
  • No
193. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Not applicable
194. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
This question is relevant to indicator 1.7.1 of the Strategic Plan
  • None
196. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
Article 27 – Liability and Redress
198. Has your country ratified or acceded to the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
199. If you answered No to question 198, is there any national process in place towards becoming a Party?
  • Yes
200. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
This question is relevant to indicator 2.4.1 of the Strategic Plan
  • No
201. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
This question is relevant to indicators 1.5.2 and 2.4.2 of the Strategic Plan
  • No
202. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress
FR
La Loi n°14/020 autorisant la ratification du Protocole de Nagoya-Kuala Lumpur a déjà été promulguée par le Chef de l'Etat et publiée au Journal officiel depuis le 17 juin 2014. Le processus est en cours pour le dépôt de l'instrument de ratification auprès du Secrétaire Général des Nations Unies.
Article 28 – Financial Mechanism and Resources
203. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
This question is relevant to indicator 1.2.5 of the Strategic Plan
  • 500,000 USD or more
Article 33 – Monitoring and reporting
204. Does your country have in place a monitoring and/or an enforcement system for the implementation of the Cartagena Protocol?
This question is relevant to indicator 3.1.6 of the Strategic Plan
a) Monitoring system:
  • Yes
b) Enforcement system:
  • Yes
205. Has your country submitted all the previous due National Reports?
  • Yes
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
FR
Au cours de la période couverte par le présent rapport, soit du mois d'août 2011 à celui d'octobre 2015, il y a lieu d'affirmer que, de manière générale, il n ' y a pas eu de progrès notables concernant la mise en œuvre du Protocole de Cartagena en RD Congo. Le cadre national de biosécurité n'est pas toujours pas mis en œuvre et le projet de loi sur la biosécurité se trouve encore en instance d'examen au Parlement.
L'absence des moyens financiers adéquats alloués à la biosécurité demeure l'une des principales causes de cette situation. Pour y remedier, la RD Congo a décidé, dans le cadre de ses allocations du Fonds pour l'Environnement Mondial pour la 5ième reconstitution (FEM-5), d'affecter près de $US800.000 à un projet sous régional pour le renforcement des capacités des laboratoires en vue de la detection des organismes vivants modifiés. L'élaboration du document dudit projet est en cours. Pour le FEM-6, un montant de $US2.500.000 a été affecté au projet de la mise en œuvre du Cadre national de biosécurité. L'élaboration de la fiche d'identification du projet (PIF) est en cours avec le concours du PNUE.
Ces deux projets permettront de jetter les bases pour la redynamisation des activités relatives à la mise en œuvre du Protocole de Cartagena en RD Congo comme le veut la stratégie et le plan d'action nationaux de la biodiversité révisés (SPANB-2) qui a retenu la biosécurité comme un de ses priorités.
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report
FR
Pas de commentaires au sujet du format du rapport.